Blog

Cathy Eng: Role for IO therapy in MSS with Dr. Neil Segal and Dr. Michael Overman

Photos taken from Cathy Eng/X

May 20, 2024, 13:23

Cathy Eng: Role for IO therapy in MSS with Dr. Neil Segal and Dr. Michael Overman

Cathy Eng shared on X:

“Last debate Great Debates & Updates on Day 1 w Dr. Neil Segal, Memorial Sloan Kettering Cancer and Dr. Michael Overman, Memorial Sloan Kettering Cancer: Is there a role for IO therapy in MSS (pMMR) patients? Yes or no? More GREAT speakers tomorrow on Day 2. Yelena Y. Janjigian.”

Source: Cathy Eng/X

Cathy Eng is a Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program at the Vanderbilt-Ingram Cancer Center. She also holds the David H. Johnson Endowed Chair of Surgical and Medical Oncology. Dr. Eng was previously a Professor of Medical Oncology at The University of Texas MD Anderson Cancer Center.

cancer Cancer Conference Cancer Management Cathy Eng Day 1 Great Debates immunotherapy IO therapy Memorial Sloan Kettering Michael Overman MSS patients Neil Segal OncoDaily Oncology oncology debate oncology speakers pMMR patients Yelena Y. Janjigian

Senator Edward Markley in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity